149 related articles for article (PubMed ID: 37279074)
1. Management of oral herpes simplex virus infections: The problem of resistance. A narrative review.
Piperi E; Papadopoulou E; Georgaki M; Dovrat S; Bar Illan M; Nikitakis NG; Yarom N
Oral Dis; 2024 Apr; 30(3):877-894. PubMed ID: 37279074
[TBL] [Abstract][Full Text] [Related]
2. Management of acyclovir-resistant herpes simplex virus.
Chilukuri S; Rosen T
Dermatol Clin; 2003 Apr; 21(2):311-20. PubMed ID: 12757254
[TBL] [Abstract][Full Text] [Related]
3. Novel mutations in the thymidine kinase and DNA polymerase genes of acyclovir and foscarnet resistant herpes simplex viruses infecting an immunocompromised patient.
Chibo D; Mijch A; Doherty R; Birch C
J Clin Virol; 2002 Aug; 25(2):165-70. PubMed ID: 12367650
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC).
Snoeck R; Andrei G; Gérard M; Silverman A; Hedderman A; Balzarini J; Sadzot-Delvaux C; Tricot G; Clumeck N; De Clercq E
Clin Infect Dis; 1994 Apr; 18(4):570-8. PubMed ID: 8038312
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up of HIV-infected patients once diagnosed with acyclovir-resistant herpes simplex virus infection.
Seang S; Boutolleau D; Burrel S; Regnier S; Epelboin L; Voujon D; Valantin MA; Katlama C; Agut H; Caumes E
Int J STD AIDS; 2014 Aug; 25(9):676-82. PubMed ID: 24535691
[TBL] [Abstract][Full Text] [Related]
6. Infection due to acyclovir resistant herpes simplex virus in patients undergoing allogeneic hematopoietic stem cell transplantation.
Venard V; Dauendorffer JN; Carret AS; Corsaro D; Edert D; Bordigoni P; Le Faou A
Pathol Biol (Paris); 2001 Sep; 49(7):553-8. PubMed ID: 11642018
[TBL] [Abstract][Full Text] [Related]
7. Herpes simplex virus resistance to acyclovir: clinical relevance.
Pottage JC; Kessler HA
Infect Agents Dis; 1995 Sep; 4(3):115-24. PubMed ID: 8548189
[TBL] [Abstract][Full Text] [Related]
8. Novel mutations in antiviral multiresistant HSV-2 genital lesion: A case report.
Khellaf L; Bouscarat F; Burrel S; Fidouh N; Hachon L; Bucau M; Lariven S; Boutolleau D; Joly V; Ghosn J; Le Pluart D; Thy M
J Med Virol; 2022 Dec; 94(12):6122-6126. PubMed ID: 35973907
[TBL] [Abstract][Full Text] [Related]
9. Acyclovir resistance in herpes simplex virus type I encephalitis: a case report.
Bergmann M; Beer R; Kofler M; Helbok R; Pfausler B; Schmutzhard E
J Neurovirol; 2017 Apr; 23(2):335-337. PubMed ID: 27787806
[TBL] [Abstract][Full Text] [Related]
10. Oral topical cidofovir: novel route of drug delivery in a severely immunosuppressed patient with refractory multidrug-resistant herpes simplex virus infection.
Sims CR; Thompson K; Chemaly RF; Shpall EJ; Champlin RE; Safdar A
Transpl Infect Dis; 2007 Sep; 9(3):256-9. PubMed ID: 17605730
[TBL] [Abstract][Full Text] [Related]
11. Topical Treatment of Acyclovir-Resistant Herpes Simplex Virus Stomatitis after Allogeneic Hematopoietic Cell Transplantation.
Heidenreich D; Kreil S; Mueller N; Jawhar M; Nolte F; Hofmann WK; Klein SA
Oncol Res Treat; 2020; 43(12):672-678. PubMed ID: 33070144
[TBL] [Abstract][Full Text] [Related]
12. Herpesvirus resistance to antiviral drugs: a review of the mechanisms, clinical importance and therapeutic options.
Reusser P
J Hosp Infect; 1996 Aug; 33(4):235-48. PubMed ID: 8864937
[TBL] [Abstract][Full Text] [Related]
13. Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management.
Piret J; Boivin G
Antimicrob Agents Chemother; 2011 Feb; 55(2):459-72. PubMed ID: 21078929
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of foscarnet-resistant herpes simplex stomatitis with intravenous cidofovir in a child.
Bryant P; Sasadeusz J; Carapetis J; Waters K; Curtis N
Pediatr Infect Dis J; 2001 Nov; 20(11):1083-6. PubMed ID: 11734717
[TBL] [Abstract][Full Text] [Related]
15. Intravenous foscarnet in the management of acyclovir-resistant herpes simplex virus type 2 in acute retinal necrosis in children.
Khurana RN; Charonis A; Samuel MA; Gupta A; Tawansy KA
Med Sci Monit; 2005 Dec; 11(12):CS75-8. PubMed ID: 16319793
[TBL] [Abstract][Full Text] [Related]
16. Treatment of acyclovir-resistant herpetic ulceration with topical foscarnet and antiviral sensitivity analysis.
Pechère M; Wunderli W; Trellu-Toutous L; Harms M; Saura JH; Krischer J
Dermatology; 1998; 197(3):278-80. PubMed ID: 9812037
[TBL] [Abstract][Full Text] [Related]
17. [Herpes simplex virus resistance to antivirals].
Burrel S; Topalis D; Boutolleau D
Virologie (Montrouge); 2020 Oct; 24(5):325-342. PubMed ID: 33111706
[TBL] [Abstract][Full Text] [Related]
18. Current Drugs to Treat Infections with Herpes Simplex Viruses-1 and -2.
Sadowski LA; Upadhyay R; Greeley ZW; Margulies BJ
Viruses; 2021 Jun; 13(7):. PubMed ID: 34202050
[TBL] [Abstract][Full Text] [Related]
19. Testing of herpes simplex virus for resistance to antiviral drugs.
Sauerbrei A; Deinhardt S; Zell R; Wutzler P
Virulence; 2010; 1(6):555-7. PubMed ID: 21178503
[TBL] [Abstract][Full Text] [Related]
20. [Acyclovir-resistant herpes exulcerans et persistens. Type II].
Klammer M; Kuhn A; Ruzicka T; Stege H
Hautarzt; 2003 Apr; 54(4):362-4. PubMed ID: 12669211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
